VENTRIKELUNTERSTÜTZUNGSVORRICHTUNG

European patent · EP4039321 · In force

Register entry

Publication number
EP4039321
Application number
EP22155936
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 10, 2019
Published
Aug 10, 2022
Granted
Mar 25, 2026
Protection ends at the latest
Jan 9, 2039
Next annual fee due
Jan 31, 2027
IPC classes
A61M 60/237 (2021.01)
A61M 60/13 (2021.01)
A61M 60/414 (2021.01)
A61M 60/808 (2021.01)
A61M 60/812 (2021.01)
A61M 60/816 (2021.01)
A61M 60/833 (2021.01)
Priority
US 201862615538 P 10.01.2018
US 201862665718 P 02.05.2018
US 201862681868 P 07.06.2018
US 201862727605 P 06.09.2018
Divided from
EP19704873
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 25, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.03.2026

Parties

Holder

Magenta Medical Ltd.

Haofeh 1, 6092000 Kadima, IL

Inventor

TUVAL, Yosi

4050426 Even, Yehuda, IL

SOHN, Zev

4485500 Karnei, Shomron, IL

SCHWAMMENTHAL, Ehud

4341103 Raanana, IL

LUBINSKY, Gad

4069600, Ein Vered, IL

GLOZMAN, Daniel

Kfar Yona 4034723, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.